PRAC January 2023 - recommendations for Janus kinase (JAK) inhibitors and information about Zolgensma
Alignment of dose recommendations for Janus kinase (JAK) inhibitors in patients with certain risk factors and New safety information for healthcare professionals for Zolgensma